Effect of Nutrition in the Treatment of Vaginitis

Sponsor
Osmaniye Korkut Ata University (Other)
Overall Status
Completed
CT.gov ID
NCT05882851
Collaborator
(none)
106
1
3.9
27.1

Study Details

Study Description

Brief Summary

Vaginitis is an inflammation or infection of the vagina. It is successfully treated for causative pathogenesis. However, it can be recurrent or treatment-resistant vaginitis. The investigator's aim in this study is to investigate the effect of nutrition and risk factors on the failure of vaginitis treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: determination of the current nutritional status of patients

Detailed Description

Predictively investigated patients diagnosed with vaginitis in the Gynecology and Obstetrics Clinic between January 2022 and April 2022. Patients with a diagnosis of vaginal infection, which were planned for medical treatment, who came for a follow-up examination, whose treatment effectiveness was re-evaluated, and whose data were complete were included in the study. Patients with co-existing gynecological diseases, who did not use the recommended medical treatment regularly, did not come to the follow-up examination within the recommended time, and could not evaluate the effectiveness of the treatment were excluded from the study.

The Obstetrician and Gynecologist gave medical treatment to all patients diagnosed with vaginal infection. The patient was called for control two weeks later. The patients included in the study were divided into two groups, those who recovered after treatment (group 1) and those who were resistant to treatment (group 2) and were compared.

Demographic data (age, gender), menopause, presence of diabetes mellitus, medical history, body mass index (BMI), total body fat and abdominal fat ratio, daily fiber consumption, carbohydrate percentage in the diet, and simple sugar ratio were recorded for the patients included in the study. In addition, the presence of birth in her medical history, delivery technique (vaginal, cesarean section), and history of recurrent vaginitis were questioned and recorded.

Anthropometric measurement Body weight and height measurements of the patients were made. Body mass index was calculated as weight (kilograms) / height squared (square meters).

Body fat measurement TANITA device is a device with 8 electrodes, working with 50 kHz constant current (hand to hand, foot to foot), measuring fat ratio, muscle mass and lean mass value for five different regions (right and left arm, right and left leg, trunk) with 5 different current waves. The measurements were carried out considering the working principles of the bioelectrical impedance analysis (BIA) device. Total body fat and abdominal fat ratio were measured with Tanita. Measurements were calculated as a percentage (%) and recorded.

Nutritional Consumption Record (BeBiS). In the study, information about the patient's diet and the carbohydrate, fat and protein ratios consumed in the diet was obtained by questioning the daily consumed foods when the patient came to the control. The three-day food consumption of the patients was recorded using the BeBis program. First, the percentage of carbohydrates and simple sugars (%) of dietary food intake was calculated and recorded. In addition, the daily pulp consumption amount (grams) was recorded.

Study Design

Study Type:
Observational
Actual Enrollment :
106 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Investigation of the Effect of Nutrition and Risk Factors on the Failure of Vaginitis Treatment
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Apr 30, 2022

Arms and Interventions

Arm Intervention/Treatment
grup 1

Those who recover after vaginitis treatment

Behavioral: determination of the current nutritional status of patients
No intervention was made on the patients. Nutritional status was recorded during the treatment process. Current nutritional status and other risk factors were compared according to recovery status after treatment.

grup 2

those who were resistant to treatment

Behavioral: determination of the current nutritional status of patients
No intervention was made on the patients. Nutritional status was recorded during the treatment process. Current nutritional status and other risk factors were compared according to recovery status after treatment.

Outcome Measures

Primary Outcome Measures

  1. determination of the current nutritional status of patients [up to 1 week]

    Three-day food consumption of the patients was recorded using the BeBis program. First, daily consumption of carbohydrates, proteins, fats was recorded in grams, and the percentage of carbohydrates and simple sugars (%) of total energy intake was calculated and recorded. In addition, daily pulp consumption amount (gram) was recorded.

Secondary Outcome Measures

  1. comparison of vaginitis treatment results and nutritional analysis results, determination of the effect of nutrition on treatment [up to 3 week]

    At the end of the four-week medical Vaginitis treatment administered by the doctor, the patients who responded positively to the treatment and were resistant to the treatment were divided into groups and the results of the food consumption analysis on Bebis were carbohydrate, protein, fat consumption amount (gram), the percentage of carbohydrate and sugar in total energy, and other risk factors (the presence of birth in The effects of macronutrients and simple sugar consumption on the treatment of vaginitis were determined by comparing each medical history, delivery technique (vaginal, cesarean section), and history of recurrent vaginitis were questioned and recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • admitted to the Gynecology and Obstetrics Clinic with a diagnosis of vaginal infection and medical treatment was planned,

  • regular check-up

  • agreeing to participate in the research,

  • not pregnant

  • over 18 years old

Exclusion Criteria:
  • under 18 years old,

  • pregnant,

  • who refused to participate in the research,

  • who did not come to their check-ups on time for treatment

  • who did not come to their check-ups on time for treatment

  • diagnosed with a psychiatric disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aybala Tazeoğlu Merkez Osmaniye Turkey 80000

Sponsors and Collaborators

  • Osmaniye Korkut Ata University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
AYBALA TAZEOGLU, assistant professor, Osmaniye Korkut Ata University
ClinicalTrials.gov Identifier:
NCT05882851
Other Study ID Numbers:
  • OsmaniyeKAUnad
First Posted:
May 31, 2023
Last Update Posted:
May 31, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by AYBALA TAZEOGLU, assistant professor, Osmaniye Korkut Ata University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 31, 2023